Sanofi Biologics (300298.SZ) announced its semi-annual performance, with net profit attributable to shareholders reaching 221 million yuan, an increase of 22.52% year-on-year.

Zhizhong Finance APP reported that Sannuo Biotechnology (300298.SZ) has published its interim report for the first half of 2026. In the first half of 2026, the company achieved operating income of 2.537 billion yuan, a year-on-year increase of 12.08%; the net profit attributable to the shareholders of the listed company was 221 million yuan, a year-on-year increase of 22.52%; the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 210 million yuan, a year-on-year increase of 32.87%; basic earnings per share were 0.4096 yuan.